{"title":"Clinical use of immune serum globulin as replacement therapy in patients with primary immunodeficiency syndromes.","authors":"S A Schwartz","doi":"10.1007/978-1-4612-0417-6_1","DOIUrl":null,"url":null,"abstract":"<p><p>IVIG is the definitive therapy for primary immunodeficiency diseases associated with hypogammaglobulinemia or specific antibody deficiencies. Administration of IVIG is relatively safe, but occasional adverse reactions are usually self-limited and generally are not an indication for stopping therapy. Home administration of IVIG has found increasing favor among treating physicians and their patients.</p>","PeriodicalId":77073,"journal":{"name":"Clinical reviews in allergy","volume":"10 1-2","pages":"1-12"},"PeriodicalIF":0.0000,"publicationDate":"1992-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"12","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical reviews in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/978-1-4612-0417-6_1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 12
Abstract
IVIG is the definitive therapy for primary immunodeficiency diseases associated with hypogammaglobulinemia or specific antibody deficiencies. Administration of IVIG is relatively safe, but occasional adverse reactions are usually self-limited and generally are not an indication for stopping therapy. Home administration of IVIG has found increasing favor among treating physicians and their patients.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
